Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Amortization of Deferred Charges (2019 - 2020)

Historic Amortization of Deferred Charges for Neurogene (NGNE) over the last 2 years, with Q3 2020 value amounting to $253000.0.

  • Neurogene's Amortization of Deferred Charges rose 95416.67% to $253000.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $808000.0, marking a year-over-year change of. This contributed to the annual value of $320000.0 for FY2014, which is 218571.43% up from last year.
  • As of Q3 2020, Neurogene's Amortization of Deferred Charges stood at $253000.0, which was up 95416.67% from $3000.0 recorded in Q2 2020.
  • In the past 5 years, Neurogene's Amortization of Deferred Charges ranged from a high of $528000.0 in Q1 2020 and a low of $3000.0 during Q2 2020